Dear Members,
You are invited to join Drs. Daniel Weiner and Johan Gabrielsson for the 16th
Advanced Level Workshop on Pharmacokinetic-Pharmacodynamic Data Analysis in San
Diego, CA. Secure your place by registering early and receive a 20% discount!
(expires December 15th)
Interested in a custom on-site training course? Follow the link to view the
benefits of on-site training and to request a proposal:
http://info.certara.com/contact-us-for-custom-on-site-training
16th Advanced Level Workshop on Pharmacokinetic - Pharmacodynamic Data
https://www.certara.com/training/classes/72
February 17-20, 2015
San Diego, CA
Register Here: https://www.certara.com/training/classes/72
Learn to apply advanced approaches for conducting PK/PD analysis. This course
aims to give the course participants confidence and encouragement to have a go
at PK/PD and to practice PK/PD data analysis on real life case studies from
discovery, preclinical and development. The program is comprised of lectures
and group exercises with discussion, combined with hands-on PK/PD data analysis
sessions.
Who should attend?
Scientists with at least five years of experience in PK/PD modeling. Qualified
graduate students.
Topics include:
Dose-response-time analysis, advanced principles of turnover modeling including
modeling
tolerance and rebound, approaches to TMDD modeling, approaches to optimizing
sampling collection times, modeling PD effects for combination drug treatments,
pattern recognition, and translational aspects of PK/PD modeling.
Course includes:
* Complimentary copy of Pharmacokinetic & Pharmacodynamic Data Analysis
[with CDROM]
by Johan Gabrielsson and Dan Weiner.
* Lectures, group exercises with discussion, and hands-on PK/PD data
analysis including
population PK/PD modeling using Phoenix WinNonlin and NLME.
* Discussions and exercises will enable participants to master
state-of-the-art approaches to real-life problems.
Daniel Weiner Ph.D.
Dr. Weiner has extensive drug development experience and has served as an
expert consultant
to the U.S. Food and Drug Administration (FDA) on pharmacokinetic modeling and
bioequivalence assessment. Prior to his previous tenure with Pharsight as a
Senior Vice President, Dr. Weiner held several management positions including
Head, Biostatistics, Merrell Dow Pharmaceuticals; Vice President, Statistical
Consultants, Inc.; Vice President, Syntex Development Research; Senior Vice
President and Principal Scientist, Quintiles, and most recently, Senior Vice
President and Global Head of Clinical Development at IVAX Research.
Johan Gabrielsson Ph.D.
Johan Gabrielsson has been Senior Principal Scientist at AstraZeneca R&D
Mölndal. His responsibilities included kinetic/dynamic related project tasks in
the CV & GI & CNS & Cancer & Biologics areas. He is a co-author of the textbook
'Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications'
4th ed. (2006). He is professor of Integrative Pharmacology at the Swedish
Agricultural University in Uppsala, Sweden. He is also academically affiliated
with Dept. of Pharmaceutics, Univ. Tennessee and University of Manchester.
He has published extensively in the field of pharmacokinetic-pharmacodynamic
modelling and reasoning, and has run numerous courses internally and externally
in the area of biological data analysis since 1985 in Europe, the US and Asia
(>4000 participants) at both the undergraduate and graduate level. His research
focuses on modelling different aspects of endogenous turnover, such as
functional tolerance and rebound phenomena, physiological limits and
target-mediated drug disposition in collaboration with Professor LA Peletier,
Leiden University. He has been external examiner on several PhD Theses abroad.
Kind regards,
Andre Keller
Certara(tm)
5520 Dillard Dr., Suite 260
Cary, NC 27518
Tel +1-919-852-4611
http://www.certara.com/